Teva Can't Toss Securities Suit Over Alleged Drug Kickbacks

By Craig Clough (March 25, 2022, 7:43 PM EDT) -- A Pennsylvania federal judge Friday denied Teva Pharmaceuticals' motion to dismiss a proposed investor class action alleging the company lied about illegal kickback payments it made to cover Medicare copayments of patients taking its multiple sclerosis drug, saying the suit plausibly argues Teva wrongly attributed its success to "legitimate business factors."...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!